Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-finding study of NT 201 injection into the soft palate for habitual snoring
2011-001779-38Phase 2Completed
- Sponsor
- Merz
- Start
- Aug 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in habitual snoring comparing NT 201 unilateral soft palate injection with Placebo unilateral soft palate injection (2 arms). Primary endpoint: Relative change from baseline in Snoring Index at week 4. Started Aug 2011; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
habitual snoring
Beyond the preview
Go deeper on 2011-001779-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001779-38.